Furthermore, the mRNA expression levels of VEGF (angiogenesis), Oct-4, and Nanog (cancer stemness) were suppressed by ~50% for the OPT-0139 5 or 20 mg/kg-injected group (Figure 6C–E). The gene discussed is NANOG; the disease is cancer.